Contraindicated. Coadministration of doravirine with a strong CYP3A inducer may reduce doravirine plasma concentrations and/or effects. Potential for loss of virologic reaction and achievable resistance to doravirine.pentobarbital improves effects of ifosfamide by impacting hepatic enzyme CYP2B6 metabolism. Use Warning/Check. Coadministration of if